GE HealthCare Technologies (NASDAQ:GEHC) Downgraded to "Hold" Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded GE HealthCare (NASDAQ:GEHC) from "Buy" to "Hold", and the stock's consensus rating is currently Hold with an average analyst target price of $92.17 (7 Buy, 6 Hold, 1 Sell).
• GE HealthCare beat quarterly estimates with $1.44 EPS and $5.70 billion in revenue (up 7.1% YoY) and set FY2026 guidance of $4.95–5.15 EPS while analysts expect about $4.68 for the year.
• Major institutional buying has driven large positions from firms like Auto Owners Insurance, Norges Bank and Dodge & Cox, leaving institutions owning roughly 82.06% of the company's shares.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Saturday.

Other equities research analysts also recently issued research reports about the company. Weiss Ratings reissued a "hold (c+)" rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Morgan Stanley upped their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. Jefferies Financial Group increased their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a "buy" rating in a research report on Thursday, December 11th. The Goldman Sachs Group restated a "buy" rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Finally, Piper Sandler raised their price objective on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an "overweight" rating in a research note on Friday, January 30th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $92.17.

GE HealthCare Technologies Stock Down 1.1%

GEHC opened at $69.61 on Friday. The stock has a fifty day moving average of $79.22 and a 200-day moving average of $78.38. The company has a market capitalization of $31.72 billion, a P/E ratio of 15.26, a P/E/G ratio of 1.55 and a beta of 1.03. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the company posted $1.45 earnings per share. GE HealthCare Technologies's revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current year.

Hedge Funds Weigh In On GE HealthCare Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of GEHC. Auto Owners Insurance Co lifted its stake in GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Norges Bank bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $596,024,000. Dodge & Cox boosted its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company's stock valued at $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth $533,655,000. Finally, Capital Research Global Investors grew its holdings in GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock worth $1,875,400,000 after buying an additional 4,998,154 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.